<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1016/j.hrthm.2021.05.023</dc:identifier><dc:language>eng</dc:language><dc:creator>B, Jáuregui</dc:creator><dc:creator>D, Penela</dc:creator><dc:creator>J, Fernández-Armenta</dc:creator><dc:creator>J, Acosta</dc:creator><dc:creator>C, Terés</dc:creator><dc:creator>D, Soto-Iglesias</dc:creator><dc:creator>E, Silva</dc:creator><dc:creator>A, Ordóñez</dc:creator><dc:creator>Antonio R, San</dc:creator><dc:creator>A, Chauca</dc:creator><dc:creator>JM, Carreño</dc:creator><dc:creator>C, Scherer</dc:creator><dc:creator>A, Berruezo</dc:creator><dc:title>Impact of a Pre-defined Pacemapping Protocol Use for Ablation of Infrequent Premature Ventricular Complexes: A Prospective, Multicenter Study.</dc:title><dc:identifier>ART-2021-146814</dc:identifier><dc:description>Background
Pacemapping (PM) is a useful maneuver for aiding premature ventricular complex (PVC) ablation. Its standalone clinical value is still to be defined.
Objectives
The purpose of this study was to analyze the efficacy of a predefined PM protocol for low-burden PVC ablation, regardless of their site of origin (SOO) and the presence of structural heart disease.
Methods
This was a prospective, nonrandomized, multicenter study. The PM protocol was performed when &lt;1 PVC/min was found. The “target area” was delimited by the 3 best matching points &gt;94% correlation, and 3 radiofreqency (RF) applications were delivered.
Results
Of 185 patients, 105 (57%) underwent activation mapping, 60 (32%) were PM-guided, and 20 (11%) were canceled due to absence of PVCs. Baseline QRS, PVC burden, and outflow tract origin were independent predictors of PM-guided ablation. A higher proportion of right ventricular outflow tract SOO in the PM group (52% vs 40%; P = .03) was observed. Mean target area was 0.6 ± 0.9 cm2. Mean 10-ms isochronal area in local activation time (LAT)-guided procedures was higher (1.7 ± 2.3 cm2; P &lt;.001). Mean number of PM matching points acquired was 39 ± 21 (range 6–98). Mean mapping and RF times were similar in both groups. However, significantly shorter procedural (53 ± 24 vs 61 ± 26 minutes; P = .04) as well as RF times (111 ± 51 vs 149 ± 149 seconds; P = .05) were needed in the PM group using the proposed protocol. Global clinical success reached 87% for the PM group and 90% (P = .58) the for LAT mapping group.
Conclusion
When LAT mapping is precluded, application of a PM-guided ablation protocol directed to &gt;94% matching correlation target area is a more efficient alternative with comparable clinical results.
ed to &gt;94% matching correlation target area is a more efficient alternative with comparable clinical results.</dc:description><dc:date>2021</dc:date><dc:source>http://zaguan.unizar.es/record/165365</dc:source><dc:doi>10.1016/j.hrthm.2021.05.023</dc:doi><dc:identifier>http://zaguan.unizar.es/record/165365</dc:identifier><dc:identifier>oai:zaguan.unizar.es:165365</dc:identifier><dc:identifier.citation>HEART RHYTHM 18, 10 (2021), 1709-1716</dc:identifier.citation><dc:rights>by-nc-nd</dc:rights><dc:rights>https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>